Not applicableStudy completedNCT01466257What this trial is testingBiomarkers in Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer ECOG-ACRIN Cancer Research Group 70
Not applicableStudy completedNCT01466244What this trial is testingBiomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397Who this might be right forHead and Neck Cancer Eastern Cooperative Oncology Group 42
Testing effectiveness (Phase 2)Study completedNCT00033618What this trial is testingIxabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+31 more National Cancer Institute (NCI) 144
Testing effectiveness (Phase 2)Study completedNCT04541355What this trial is testingSodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With CisplatinWho this might be right forClinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Advanced Head and Neck Squamous Cell Carcinoma+26 more Hyunseok Kang, MD
Testing effectiveness (Phase 2)Ended earlyNCT01267240What this trial is testingCapecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerWho this might be right forParanasal Sinus Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+14 more National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT01256385What this trial is testingTemsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous TherapyWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+33 more National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Study completedNCT01806675What this trial is testing18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT00063895What this trial is testingErlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckWho this might be right forRecurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+27 more National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00507767What this trial is testingDasatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT02048020What this trial is testingPaclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerWho this might be right forHuman Papilloma Virus InfectionStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Larynx+13 more Jonsson Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00103259What this trial is testingBortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckWho this might be right forRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+22 more National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Study completedNCT01816984What this trial is testingPI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more University of Chicago 12
Large-scale testing (Phase 3)WithdrawnNCT01545687What this trial is testingCD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and ChemotherapyWho this might be right forHead and Neck CancerOral Complications of Radiation TherapyPain+1 more Alliance for Clinical Trials in Oncology
Large-scale testing (Phase 3)Active Not RecruitingNCT00588770What this trial is testingChemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaWho this might be right forNeck Squamous Cell Carcinoma of Unknown PrimaryRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+32 more National Cancer Institute (NCI) 403
Not applicableEnded earlyNCT02388932What this trial is testingStereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck CancerWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma+25 more Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT03342911What this trial is testingNivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by SurgeryWho this might be right forName Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma+19 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 34
Not applicableStudy completedNCT00068497What this trial is testingGefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerWho this might be right forAnaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01064479What this trial is testingCombination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckWho this might be right forMetastatic Squamous Cell Carcinoma of the HypopharynxMetastatic Squamous Cell Carcinoma of the LarynxMetastatic Squamous Cell Carcinoma of the Oral Cavity+21 more M.D. Anderson Cancer Center 123
Testing effectiveness (Phase 2)Study completedNCT00096512What this trial is testingS0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more National Cancer Institute (NCI) 40
Not applicableStudy completedNCT02245100What this trial is testingCirculating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage IIIA Non-small Cell Lung Cancer+27 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 130